Joel N. Gossner

Represented one of the U.S.’s largest private companies in strategic merger and acquisition transactions, including advising its software business unit in its acquisition of a pharmacy management software company, and counseling its wholesale drug distribution business unit in its acquisitions of an independent pharmacy chain and a pharmaceutical distributor.

Represented a Fortune 500 company in strategic transactions throughout the U.S., including acquisitions in the e-commerce and distribution industries

Represented a closely held cleaning and sanitation products manufacturer in its sale to a Fortune 500 company

Represented an over-the-counter pharmaceutical company in its acquisition of a portfolio of commercial and pipeline products from a major pharmaceuticals company

Represented a medical device start-up in its sale to an NYSE-listed purchaser

Represented a manufacturer and packager of pharmaceuticals, over-the-counter drugs and dietary supplements in the negotiation of a supply agreement valued in excess of $100 million with a large, independent provider of over-the-counter products

Advised leading provider of pharmacy information systems, and one of the US’s largest private companies, in its strategic acquisition of a pharmacy management software company.

Represented a restaurant chain owner/operator and a debtor-in-possession in a 363 sale to its “stalking horse” bidder

Represented early stage Internet-of-Things company in a Series Seed equity financing transaction and an early stage employee benefits company in a Series A financing transaction